home.social

#clinicaltrials — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #clinicaltrials, aggregated by home.social.

  1. europesays.com/dk/176797/ People switching from weight-loss injections to Novo’s Wegovy® pill lost 4.1% body weight on average after three months, according to real-world data presented at EASD2026 #Biotechnology #ClinicalTrials&MedicalDiscoveries #FitnessWellness #HealthCare&Hospitals #MedicalPharmaceuticals #NovoNordisk #NOVONORDISKINC #Pharmaceuticals #PollsAndResearch #Surveys

  2. Milvexian changed blood-clotting biology—but didn’t improve outcomes after acute coronary syndrome. A powerful reminder that successful mechanisms don’t always translate into clinical benefit.
    #Cardiology #ClinicalTrials #HeartHealth #Telehealth #MedicalResearch

  3. Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

    The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

    justpaste.in/news/enveda-secur

    #clinicaltrials #Enveda #InBrief #AI #BiotechampHealth

  4. Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

    The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

    justpaste.in/news/enveda-secur

    #clinicaltrials #Enveda #InBrief #AI #BiotechampHealth

  5. Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

    The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

    justpaste.in/news/enveda-secur

    #clinicaltrials #Enveda #InBrief #AI #BiotechampHealth

  6. Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

    The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

    justpaste.in/news/enveda-secur

    #clinicaltrials #Enveda #InBrief #AI #BiotechampHealth

  7. Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

    The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

    justpaste.in/news/enveda-secur

    #clinicaltrials #Enveda #InBrief #AI #BiotechampHealth

  8. This Startup Is Using #AI to Fight Off a Future AI #Pandemic
    #RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
    The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
    wsj.com/health/this-startup-is
    archive.is/20260928010231/http

  9. This Startup Is Using #AI to Fight Off a Future AI #Pandemic
    #RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
    The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
    wsj.com/health/this-startup-is
    archive.is/20260928010231/http

  10. This Startup Is Using to Fight Off a Future AI
    is using to design for novel pathogens—before future AI systems create them
    The company, in which OpenAI is a lead investor, says it has raised $36 million. Human of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
    wsj.com/health/this-startup-is
    archive.is/20260928010231/http

  11. This Startup Is Using #AI to Fight Off a Future AI #Pandemic
    #RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
    The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
    wsj.com/health/this-startup-is
    archive.is/20260928010231/http

  12. This Startup Is Using #AI to Fight Off a Future AI #Pandemic
    #RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
    The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
    wsj.com/health/this-startup-is
    archive.is/20260928010231/http